Table 2.
Sample collected at baseline visit (1994–5) | Sample collected in 2007 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
ID | Date of sample collection |
Anti- CMV IgG titers* (EU/ml) |
CMV DNA |
IL-6 (pg/ml) |
CMV pp65 (NLV) - CD8+ T cells (%) |
Date of sample collection |
Anti- CMV IgG titers (EU/ml) |
CMV DNA |
IL-6 (pg/ml) |
CMV pp65 (NLV) - CD8+ T cells (%) |
1 | 11/21/1994 | 1.73 | − | 1.91 | 11/07/2007 | -** | − | 1.04 | ||
2 | 10/10/1995 | - | − | 1.14 | 11/06/2007 | - | − | 0.95 | ||
3 | 08/10/1995 | - | − | 1.04 | 10/30/2007 | - | − | 0.93 | ||
4 | 07/03/1995 | - | − | 1.22 | 0.04 | 11/20/2007 | - | − | 1.51 | 0.02 |
5 | 06/13/1995 | 14.05 | − | 1.28 | 0.02 | 11/21/2007 | 15.51 | − | 0.70 | 0.02 |
6 | 01/25/1995 | 7.35 | − | 0.55 | 11/16/2007 | 9.76 | − | 0.38 | ||
7 | 09/13/1995 | 9.79 | − | 1.24 | 12/19/2007 | 11.13 | − | 0.89 | ||
8 | 12/22/1994 | 11.23 | − | 1.14 | 0.02 | 10/29/2007 | 10.91 | − | 1.44 | 0.01 |
9 | 12/05/1995 | 10.16 | + | 3.38 | 11/20/2007 | 12.88 | + | 3.88 | ||
10 | 03/16/1995 | 8.15 | + | 2.51 | 11/27/2007 | 9.24 | + | 2.36 | ||
11 | 12/04/1995 | 11.48 | + | 3.53 | 0.85 | 11/20/2007 | 11.01 | + | 3.43 | 0.88 |
12 | 09/27/1995 | 17.16 | + | 4.11 | 0.64 | 11/21/2007 | 17.48 | + | 3.43 | 0.83 |
13 | 06/21/1995 | 7.54 | + | 2.58 | 11/20/2007 | 7.753 | + | 2.41 | ||
14 | 10/19/1995 | 16.53 | + | 2.5 | 10/22/2007 | 16.31 | + | 2.89 | ||
15 | 12/11/1995 | 3.18 | + | 2.84 | 12/07/2007 | 5.16 | + | 4.24 |
Values below the predetermined cut-off value for CMV-seropositivity (1.2 EU/ml) were recorded (−);
The absolute anti-CMV IgG titer value was 1.12 EU/ml.